Yourgene Health Plc (YGEN):企業の財務・戦略的SWOT分析

◆英語タイトル:Yourgene Health Plc (YGEN) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY0902
◆発行会社(調査会社):GlobalData
◆発行日:2020年1月
◆ページ数:52
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Yourgene Health Plc (YGEN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Yourgene Health Plc (Yourgene Health), formerly Premaitha Health Plc, is a molecular diagnostics company, which focuses on the development of genetic screening tests including novel tests for non-invasive prenatal screening (NIPT). Its flagship product, the IONA test is an advanced NIPT test that assists in estimating the risk of trisomy. The IONA test helps obviate the expensive, unnecessary and invasive diagnostic procedures such as amniocentesis. The company provides NIPT tests and services to clinical laboratories and healthcare professionals. The company offers its products directly to customers in Europe. It operates through a subsidiary, Yourgene Bioscience, in Taiwan, which provides it expanded market access in Asia. Yourgene Health is headquartered in Manchester, England, the UK.

Yourgene Health Plc Key Recent Developments

Dec 02,2019: Yourgene Health: Half-year Report
Nov 28,2019: Yourgene Health: Opening of new facilities and corporate HQ
Oct 14,2019: Yourgene Health: Half year trading update
Sep 26,2019: Yourgene Health: CE-IVD Certification renewal
Aug 19,2019: Yourgene Health: Change of Registered Office

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Yourgene Health Plc – Key Facts
Yourgene Health Plc – Key Employees
Yourgene Health Plc – Key Employee Biographies
Yourgene Health Plc – Key Operational Employees
Yourgene Health Plc – Major Products and Services
Yourgene Health Plc – History
Yourgene Health Plc – Company Statement
Yourgene Health Plc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Yourgene Health Plc – Business Description
Geographical Segment: Europe
Performance
Geographical Segment: Rest of the World
Performance
Geographical Segment: UK
Performance
Yourgene Health Plc – Corporate Strategy
Yourgene Health Plc – SWOT Analysis
SWOT Analysis – Overview
Yourgene Health Plc – Strengths
Yourgene Health Plc – Weaknesses
Yourgene Health Plc – Opportunities
Yourgene Health Plc – Threats
Yourgene Health Plc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Yourgene Health Plc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Yourgene Health Plc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Yourgene Health Plc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Dec 02, 2019: Yourgene Health: Half-year Report
Nov 28, 2019: Yourgene Health: Opening of new facilities and corporate HQ
Oct 14, 2019: Yourgene Health: Half year trading update
Sep 26, 2019: Yourgene Health: CE-IVD Certification renewal
Aug 19, 2019: Yourgene Health: Change of Registered Office
Aug 16, 2019: Yourgene Health: Appointment of business development sector specialist as Non-executive Director
Jul 29, 2019: Yourgene Health appoints John Brown as non-executive director
Jul 10, 2019: Yourgene Health: Results for the year ended 31 March 2019, business update and director change
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Yourgene Health Plc, Key Facts
Yourgene Health Plc, Key Employees
Yourgene Health Plc, Key Employee Biographies
Yourgene Health Plc, Key Operational Employees
Yourgene Health Plc, Major Products and Services
Yourgene Health Plc, History
Yourgene Health Plc, Subsidiaries
Yourgene Health Plc, Key Competitors
Yourgene Health Plc, Ratios based on current share price
Yourgene Health Plc, Annual Ratios
Yourgene Health Plc, Annual Ratios (Cont...1)
Yourgene Health Plc, Interim Ratios
Yourgene Health Plc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Yourgene Health Plc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Yourgene Health Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Yourgene Health Plc, Performance Chart (2015 - 2019)
Yourgene Health Plc, Ratio Charts
Yourgene Health Plc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Yourgene Health Plc, Medical Equipment, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Yourgene Health Plc (YGEN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • LPL Financial Holdings Inc (LPLA):企業の財務・戦略的SWOT分析
    LPL Financial Holdings Inc (LPLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Takeda Pharmaceutical Co Ltd (4502):企業の財務・戦略的SWOT分析
    Takeda Pharmaceutical Co Ltd (4502) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Juhl Energy Inc:企業の戦略的SWOT分析
    Juhl Energy Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Formula Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Formula Pharmaceuticals Inc (Formula Pharmaceuticals) is an oncology company that develops chimeric antigen receptor (CAR) immunotherapy for oncology and autoimmune diseases. The company’s pipeline products include CIK-CAR.CD19, used as B-lymphocyte surface antigen; CIK-CAR.CD33, used for th …
  • Liebherr-International AG:企業の戦略・SWOT・財務分析
    Liebherr-International AG - Strategy, SWOT and Corporate Finance Report Summary Liebherr-International AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • SONIFI Solutions, Inc:企業の戦略的SWOT分析
    SONIFI Solutions, Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • XenoPort Inc-製薬・医療分野:企業M&A・提携分析
    Summary XenoPort Inc (XenoPort) is a bio-pharmaceutical company which develops and commercializes internally discovered product candidates for the treatment of neurological disorders. It develops Transported Prodrugs through the modification of chemical structure of existing drugs in the market. The …
  • LVMH Moet Hennessy Louis Vuitton SA:企業の戦略・SWOT・財務情報
    LVMH Moet Hennessy Louis Vuitton SA - Strategy, SWOT and Corporate Finance Report Summary LVMH Moet Hennessy Louis Vuitton SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Organogenesis Inc-医療機器分野:企業M&A・提携分析
    Summary Organogenesis Inc (Organogenesis) is a regenerative medicine company that operates in the areas of bioactive wound healing and soft tissue regeneration. The company’s products include apligraf and dermagraft. Its dermagraft is used for the treatment of full-thickness diabetic foot ulcers. Or …
  • The Portage la Prairie Mutual Insurance Company:企業の戦略的SWOT分析
    The Portage la Prairie Mutual Insurance Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competito …
  • The Binding Site Group Ltd:製品パイプライン分析
    Summary The Binding Site Group Ltd (Binding Site) is a clinical diagnostic tools supplier that concentrates on research, development, manufacturing and distribution of immunodiagnostic assays. The company’s product portfolio includes antibodies, antigens, bulk antisera, assays for plasma protein ana …
  • GlobalData plc (PRO):企業の財務・戦略的SWOT分析
    Summary GlobalData Plc (GD), formerly Progressive Digital Media Group Plc, is a provider of data insights, analytics and information services. The company’s solutions encompass market and competitive analysis, strategic planning, mergers and acquisitions, financial decisions, legal and accounting, m …
  • Bhansali Engineering Polymers Ltd (BEPL):企業の財務・戦略的SWOT分析
    Summary Bhansali Engineering Polymers Ltd (BEPL), formerly Bhansali Steel Ltd is a petrochemical company that manufactures and markets acrylonitrile butadiene styrene. The company's products include general ABS, extrusion ABS, flame retardant ABS, ABS-GF or SAN-GF, PMMA-ABS, PVC modifier, PC or ABS …
  • Clark Public Utilities:企業の戦略的SWOT分析
    Clark Public Utilities - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Toll Brothers Inc:戦略・SWOT・企業財務分析
    Toll Brothers Inc - Strategy, SWOT and Corporate Finance Report Summary Toll Brothers Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Janssen Pharmaceuticals Inc:医療機器:M&Aディール及び事業提携情報
    Summary Janssen Pharmaceuticals Inc (Janssen), a subsidiary of Johnson & Johnson is a pharmaceutical company that develops drugs. The company offers medicines for an array of health conditions in therapeutic areas of attention deficit hyperactivity disorder, general medicine, mental health, neurolog …
  • BRT Apartments Corp.:企業の戦略・SWOT・財務情報
    BRT Apartments Corp. - Strategy, SWOT and Corporate Finance Report Summary BRT Apartments Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Citizens Energy Group:企業の戦略的SWOT分析
    Citizens Energy Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Puget Sound Energy Inc:電力:M&Aディール及び事業提携情報
    Summary Puget Sound Energy Inc (PSE), a subsidiary of Puget Energy Inc, is a utility service provider. The company offers offers services such as energy and natural gas supply, start service, power outages, natural gas safety, business services, natural gas storage and excess generation of energy. I …
  • BioScrip Inc (BIOS):企業の財務・戦略的SWOT分析
    BioScrip Inc (BIOS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆